2026-07-21T16:29:17Zhttps://repisalud.isciii.es/rest/oai/request

oai:repisalud.isciii.es:20.500.12105/150802024-11-29T21:51:43Zcom_20.500.12105_2173com_20.500.12105_2051col_20.500.12105_19597

00925njm 22002777a 4500 dc Valiente, Manuel author García-Gómez, Pedro author 2020 Vascular co-option is an alternative mechanism to interact with blood vessels used by normal cells and hijacked by cancer cells. Functional experiments using in vivo models have demonstrated that co-option of pre-existing capillary networks is a critical step for the initiation of multiorgan metastases from different cancer types. Thus targeting this process pharmacologically is a very promising strategy to prevent metastases. Vascular co-option supports the viability of disseminated tumor cells, even when they remain dormant. Additionally, targeting vascular co-option could be a valuable strategy to challenge the emergence of resistance to more conventional therapies. Tumor Vascularization. eds.Domenico Ribatti, Francesco Pezzella.London, Elsevier, 2020. En:Vascular co-option/ Pedro García Gomez, Manuel Valiente.a Zhu, Manuel Valiente. 2020, pags.33-47. https://doi.org/10.1016/C2019-0-00115-X 978-0-12-819494-2 http://hdl.handle.net/20.500.12105/15080 vascular co-option capillaries Metastasis dormancy immunosuppression aggressiveness adhesion stemness angiocrine factors Vascular co-option